Clinical Trial Update: Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating neoadjuvant therapy for locally advanced rectal cancer using fruquintinib, toripalimab, and SRT.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: West China Hospital | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN